ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,032.38
0.56%
US Tech 100
20,389.60
0.88%
다우존스 지수
44,910.65
0.42%
Bitcoin
96,515.00
-1.00%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 영국
  5. LSE
  6. Roquefort Therapeutics Plc (ROQ)

  7. Roquefort Therapeutics Plc (ROQ) 뉴스

ROQ

Roquefort Therapeutics (ROQ)

Roquefort Therapeutics Plc
일자:
정렬 기준:
 검색 관련기사 보기:LSE:ROQ
일자시간출처헤드라인심볼기업
2024/11/0716:00RNS Regulatory NewsRoquefort Therapeutics PLC Conversion of Convertible Loan NotesLSE:ROQRoquefort Therapeutics Plc
2024/11/0616:00RNS Non-RegulatoryRoquefort Therapeutics PLC STAT-6 siRNA PresentationLSE:ROQRoquefort Therapeutics Plc
2024/09/2721:56Alliance NewsAlliance NewsEARNINGS: Kendrick Resources loss narrows; Emmerson CFO to departLSE:ROQRoquefort Therapeutics Plc
2024/09/2721:56Alliance NewsAlliance NewsEARNINGS: Kendrick Resources loss narrows; Emmerson CFO to departLSE:ROQRoquefort Therapeutics Plc
2024/09/2715:00RNS Regulatory NewsRoquefort Therapeutics PLC Interim Results to 30 June 2024LSE:ROQRoquefort Therapeutics Plc
2024/09/2401:51Alliance NewsAlliance NewsRoquefort Therapeutics says MK cell therapy patent approved in JapanLSE:ROQRoquefort Therapeutics Plc
2024/09/2401:51Alliance NewsAlliance NewsRoquefort Therapeutics says MK cell therapy patent approved in JapanLSE:ROQRoquefort Therapeutics Plc
2024/09/2315:00RNS Regulatory NewsRoquefort Therapeutics PLC Grant of Japan MK Cell PatentLSE:ROQRoquefort Therapeutics Plc
2024/09/1915:00RNS Regulatory NewsRoquefort Therapeutics PLC STAT-6 siRNA Demonstrates Efficacy in ImmunologyLSE:ROQRoquefort Therapeutics Plc
2024/09/0215:00RNS Regulatory NewsRoquefort Therapeutics PLC Grant of MK Cell Patent & Licencing UpdateLSE:ROQRoquefort Therapeutics Plc
2024/06/2720:46RNS Regulatory NewsRoquefort Therapeutics PLC Results of AGMLSE:ROQRoquefort Therapeutics Plc
2024/06/2015:00RNS Regulatory NewsRoquefort Therapeutics PLC Appointment of BrokerLSE:ROQRoquefort Therapeutics Plc
2024/06/0415:00RNS Regulatory NewsRoquefort Therapeutics PLC Notice of Annual General MeetingLSE:ROQRoquefort Therapeutics Plc
2024/05/2405:25Alliance NewsAlliance NewsTRADING UPDATES: Windward wins deal; Kodal progresses at BougouniLSE:ROQRoquefort Therapeutics Plc
2024/05/2405:25Alliance NewsAlliance NewsTRADING UPDATES: Windward wins deal; Kodal progresses at BougouniLSE:ROQRoquefort Therapeutics Plc
2024/05/2315:05RNS Regulatory NewsRoquefort Therapeutics PLC Issue of Convertible Loan Notes & Board ChangesLSE:ROQRoquefort Therapeutics Plc
2024/05/2315:00RNS Regulatory NewsRoquefort Therapeutics PLC Midkine Antibody Licencing DealLSE:ROQRoquefort Therapeutics Plc
2024/04/2704:59Alliance NewsAlliance NewsEARNINGS AND TRADING: Aura confident in Tiris; Cindrigo enters GermanyLSE:ROQRoquefort Therapeutics Plc
2024/04/2704:59Alliance NewsAlliance NewsEARNINGS AND TRADING: Aura confident in Tiris; Cindrigo enters GermanyLSE:ROQRoquefort Therapeutics Plc
2024/04/2615:00RNS Regulatory NewsRoquefort Therapeutics PLC Annual Report & Financial Statements - 31 Dec 2023LSE:ROQRoquefort Therapeutics Plc
2024/04/0520:32Alliance NewsAlliance NewsIN BRIEF: Roquefort cancels fundraise after "unusual" stock movementsLSE:ROQRoquefort Therapeutics Plc
2024/04/0520:32Alliance NewsAlliance NewsIN BRIEF: Roquefort cancels fundraise after "unusual" stock movementsLSE:ROQRoquefort Therapeutics Plc
2024/04/0515:00RNS Regulatory NewsRoquefort Therapeutics PLC Response to Share Price MovementLSE:ROQRoquefort Therapeutics Plc
2024/03/1120:12Alliance NewsAlliance NewsRoquefort celebrates "significant milestones" in cancer researchLSE:ROQRoquefort Therapeutics Plc
2024/03/1120:12Alliance NewsAlliance NewsRoquefort celebrates "significant milestones" in cancer researchLSE:ROQRoquefort Therapeutics Plc
2024/03/1116:00RNS Regulatory NewsRoquefort Therapeutics PLC Positive Results: Midkine mRNA and STAT-6 siRNALSE:ROQRoquefort Therapeutics Plc
2024/02/0701:50Alliance NewsAlliance NewsIN BRIEF: Roquefort hails further MK studies, licence talks continueLSE:ROQRoquefort Therapeutics Plc
2024/02/0701:50Alliance NewsAlliance NewsIN BRIEF: Roquefort hails further MK studies, licence talks continueLSE:ROQRoquefort Therapeutics Plc
2024/02/0616:00RNS Regulatory NewsRoquefort Therapeutics PLC Operations UpdateLSE:ROQRoquefort Therapeutics Plc
2023/11/2416:00UK RegulatoryRoquefort Therapeutics PLC Change of AuditorLSE:ROQRoquefort Therapeutics Plc
 검색 관련기사 보기:LSE:ROQ

최근 히스토리

TG
EGV1
Lyxor Asset Management L...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유